{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T21:53:49Z","timestamp":1740174829689,"version":"3.37.3"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T00:00:00Z","timestamp":1721865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T00:00:00Z","timestamp":1721865600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["surg case rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Dropped head syndrome (DHS) is caused by dysfunction of the cervical musculature. It is classified into two groups according to the cause: one is weakness of the neck extensors and the other is hypercontraction of the cervical flexors associated with Parkinson\u2019s disease and other disorders. Although some drugs have previously been reported as suspected causes of DHS, we are unaware of any reports in which oxaliplatin was suspected. In this report, we describe a case of DHS during adjuvant chemotherapy for gastric cancer, along with a review of the relevant literature.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>A 72-year-old man was diagnosed with gastric cancer, cT3N0M0 cStage IIB, and underwent laparoscopic total gastrectomy with D2 lymphnode dissection and Roux-en-Y reconstruction. The operative time was 311\u00a0min, intraoperative blood loss was 40\u00a0g, and he was discharged without any post-operative complications. The histopathological diagnosis was pT4aN2M0 pStage IIIA, and S-1\u2009+\u2009oxaliplatin (SOX) therapy was started as adjuvant chemotherapy. On the 4th course of SOX, he complained of neck heaviness and a blood test revealed that his creatine kinase (CK) level was elevated to 2464\u00a0IU\/L. After consultation with an orthopedic surgeon and a neurologist, DHS due to localized cervical extensor myositis was suspected. Therefore, the 6th course of SOX was postponed, and 30\u00a0mg of oral steroids were initiated. His symptoms improved, and his CK level decreased within 2\u00a0weeks. After resuming S-1 monotherapy and tapering off oral steroids, no recurrence of symptoms has been observed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>We experienced one case of DHS during adjuvant chemotherapy for gastric cancer. If DHS develops after starting oxaliplatin, involvement of the drug should be suspected, and discontinuation of chemotherapy and introduction of oral steroids should be considered.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40792-024-01976-w","type":"journal-article","created":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T08:01:57Z","timestamp":1721894517000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dropped head syndrome suspected due to oxaliplatin used in adjuvant chemotherapy for gastric cancer: a case report"],"prefix":"10.1186","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-5518-0356","authenticated-orcid":false,"given":"Yuta","family":"Marunaka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuma","family":"Ohashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Kubota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiji","family":"Nishibeppu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirotaka","family":"Konishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Shiozaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eigo","family":"Otsuji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,7,25]]},"reference":[{"key":"1976_CR1","unstructured":"International Agency for Research on Cancer. Data visualization tools for exploring the global cancer burden in 2022. 2022. https:\/\/gco.iarc.fr\/today\/en."},{"issue":"3","key":"1976_CR2","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1634\/theoncologist.10-90003-49","volume":"10","author":"Ajani","year":"2005","unstructured":"Ajani, Jaffer A, et al. Evolving chemotherapy for advanced gastric cancer. Oncologist. 2005;10(3):49\u201358.","journal-title":"Oncologist"},{"issue":"28","key":"1976_CR3","doi-asserted-by":"publisher","first-page":"3130","DOI":"10.1200\/JCO.2014.58.3930","volume":"33","author":"SH Park","year":"2015","unstructured":"Park SH, Sohn TS, Lee J, Lim DH, Hong ME, Kim KM, et al. Phase III trial to compare adjuvant chemotherapy with capecitabine and cisplatin versus concurrent chemoradiotherapy in gastric cancer: final report of the adjuvant chemoradiotherapy in stomach tumors trial, including survival and subset analyses. J Clin Oncol. 2015;33(28):3130\u20136.","journal-title":"J Clin Oncol"},{"issue":"1 Suppl 1","key":"1976_CR4","first-page":"S23","volume":"93","author":"S Louafi","year":"2006","unstructured":"Louafi S, Mansourbakht T, Bonyhay L, Ta\u00efeb J. Oxaliplatin in gastro-intestinal tract cancer except colorectal cancer. Bull Cancer. 2006;93(1 Suppl 1):S23\u201333.","journal-title":"Bull Cancer"},{"issue":"5 Suppl 15","key":"1976_CR5","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1053\/sonc.2002.35525","volume":"29","author":"E Gamelin","year":"2002","unstructured":"Gamelin E, Gamelin L, Bossi L, Quasthoff S. Clinical aspects and molecular basis of oxaliplatin neurotoxicity: current management and development of preventive measures. Semin Oncol. 2002;29(5 Suppl 15):21\u201333.","journal-title":"Semin Oncol"},{"issue":"7","key":"1976_CR6","first-page":"81","volume":"35","author":"K Ishii","year":"2022","unstructured":"Ishii K, et al. Kubisagarishoukougun no byoutai to tiryou. MB Orthop. 2022;35(7):81\u20139 (in Japanese).","journal-title":"MB Orthop"},{"issue":"6","key":"1976_CR7","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.2169\/naika.102.1464","volume":"102","author":"T Akaishi","year":"2013","unstructured":"Akaishi T, Kikuchi A, Hasegawa T, Tateyama M, Aoki M. Case report; suspected DPP-4 inhibitor-induced dropped head syndrome. Nippon Naika Gakkai Zasshi. 2013;102(6):1464\u20136.","journal-title":"Nippon Naika Gakkai Zasshi"},{"issue":"18","key":"1976_CR8","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1212\/WNL.0b013e318271f87e","volume":"79","author":"X Chen","year":"2012","unstructured":"Chen X, Schwartz GK, DeAngelis LM, Kaley T, Carvajal RD. Dropped head syndrome: report of three cases during treatment with a MEK inhibitor. Neurology. 2012;79(18):1929\u201331.","journal-title":"Neurology"},{"issue":"1","key":"1976_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10120-022-01331-8","volume":"26","author":"Japanese Gastric Cancer Association","year":"2023","unstructured":"Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2021 (6th edition). Gastr Cancer. 2023;26(1):1\u201325.","journal-title":"Gastr Cancer"},{"issue":"8","key":"1976_CR10","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1212\/WNL.42.8.1625","volume":"42","author":"GA Suarez","year":"1992","unstructured":"Suarez GA, Kelly JJ Jr. The dropped head syndrome. Neurology. 1992;42(8):1625\u20137.","journal-title":"Neurology"},{"issue":"6","key":"1976_CR11","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/j.jos.2019.07.009","volume":"24","author":"K Endo","year":"2019","unstructured":"Endo K, Kudo Y, Suzuki H, Aihara T, Matsuoka Y, Murata K, et al. Overview of dropped head syndrome (combined survey report of three facilities). J Orthop Sci. 2019;24(6):1033\u20136.","journal-title":"J Orthop Sci"},{"key":"1976_CR12","first-page":"569","volume":"30","author":"K Ishii","year":"2017","unstructured":"Ishii K, et al. Sekitsui Sekizui sikkann to kinnisyuku\u2014Kubisagarishoukougun no byoutai to tiryou. Spine Spinal Cord. 2017;30:569\u201372 (in Japanese).","journal-title":"Spine Spinal Cord"},{"issue":"5","key":"1976_CR13","doi-asserted-by":"publisher","first-page":"921","DOI":"10.3919\/jjsa.78.921","volume":"78","author":"S Maruoka","year":"2017","unstructured":"Maruoka S, Iwahashi M, Yamamoto M, Terasawa H, Fukuda N, Kobayashi Y. Drug-related rhabdomyolysis due to oxalipatin. Nihon Rinsho Geka Gakkai Zasshi. 2017;78(5):921\u20135.","journal-title":"Nihon Rinsho Geka Gakkai Zasshi"},{"issue":"2","key":"1976_CR14","first-page":"31","volume":"17","author":"H Kajikawa","year":"2008","unstructured":"Kajikawa H, et al. Dropped head and visual and musical hallucination induced by amantadine in a case of vascular parkinsonism. J Move Disord Disabil. 2008;17(2):31\u20135.","journal-title":"J Move Disord Disabil"},{"issue":"5","key":"1976_CR15","doi-asserted-by":"publisher","first-page":"329","DOI":"10.5692\/clinicalneurol.cn-001572","volume":"61","author":"T Ota","year":"2021","unstructured":"Ota T, Yoshida K, Suzuki Y, Kuroda K, Kimura T. A case of dropped head syndrome suspected due to dipeptidyl peptidase (DPP)-4 inhibitor use. Rinsho Shinkeigaku. 2021;61(5):329\u201331.","journal-title":"Rinsho Shinkeigaku"},{"issue":"8","key":"1976_CR16","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1158\/1078-0432.CCR-21-3909","volume":"28","author":"P Chi","year":"2022","unstructured":"Chi P, et al. Phase Ib trial of the combination of imatinib and binimetinib in patients with advanced gastrointestinal stromal tumors. Clin Cancer Res. 2022;28(8):1507\u201317.","journal-title":"Clin Cancer Res"}],"container-title":["Surgical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40792-024-01976-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40792-024-01976-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40792-024-01976-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T08:10:23Z","timestamp":1721895023000},"score":1,"resource":{"primary":{"URL":"https:\/\/surgicalcasereports.springeropen.com\/articles\/10.1186\/s40792-024-01976-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,25]]},"references-count":16,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1976"],"URL":"https:\/\/doi.org\/10.1186\/s40792-024-01976-w","relation":{},"ISSN":["2198-7793"],"issn-type":[{"type":"electronic","value":"2198-7793"}],"subject":[],"published":{"date-parts":[[2024,7,25]]},"assertion":[{"value":"4 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics review is not required for case report publication at our institution.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and the accompanying images.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"174"}}